Vyant Bio Inc (VYNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,666 | -19,887 | -8,407 | N/A | N/A |
| Depreciation Amortization | 1,781 | 945 | 854 | N/A | N/A |
| Accounts receivable | -157 | -356 | -570 | N/A | N/A |
| Other Working Capital | -284 | 1,465 | -792 | N/A | N/A |
| Other Operating Activity | -2,252 | 12,759 | 3,184 | 0 | 0 |
| Operating Cash Flow | $-7,578 | $-5,073 | $-5,731 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -163 | -269 | -161 | N/A | N/A |
| Purchase Sale Intangibles | -135 | -83 | -18 | N/A | N/A |
| Other Investing Activity | -185 | 156 | -7 | 0 | 0 |
| Investing Cash Flow | $-348 | $-113 | $-168 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 3,200 | 590 | N/A | N/A |
| Debt Issued | 7,120 | 3,000 | N/A | N/A | N/A |
| Debt Repayment | -54 | -43 | -225 | N/A | N/A |
| Common Stock Issued | 635 | 50 | 2 | N/A | N/A |
| Other Financing Activity | -1,373 | -383 | 7,281 | 0 | 0 |
| Financing Cash Flow | $6,328 | $5,824 | $7,648 | $N/A | $N/A |
| Beginning Cash Position | 2,417 | 1,779 | 30 | N/A | N/A |
| End Cash Position | 820 | 2,417 | 1,779 | N/A | N/A |
| Net Cash Flow | $-1,597 | $638 | $1,749 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,578 | -5,073 | -5,731 | N/A | N/A |
| Capital Expenditure | -163 | -269 | -161 | N/A | N/A |
| Free Cash Flow | -7,740 | -5,342 | -5,892 | 0 | 0 |